Year1
- 1：
- 4
- 2：
- 5
- 3：
- 6
What is Iressa? Are there any special effects?
- - Answer In recent years, with the pollution of the environment and poor people's living and resting habits, cancers have begun to appear frequently, especially lung cancer, which has become the most common type of cancer with the highest incidence and mortality rates. Now as society With the development of lung cancer treatment, both in terms of treatment methods and treatment concepts, Iressa has begun to become a very effective treatment for lung cancer. So what exactly is going on? Oncologist at Chengdu Military Region General Hospital Zhang Qin said that Iressa is a powerful targeted small molecule anti-cancer drug that has been produced as lung cancer has become more and more serious in recent years. The famous oncology drug company AstraZeneca produces it mainly through competitive products. It binds to the growth factor receptors on the surface of lung cancer and prevents the division and expression of lung cancer cells to control and kill lung cancer cells. Generally speaking, Iressa is currently mainly suitable for the treatment of patients with non-small cell lung cancer after chemotherapy. In recent years, it has been very effective in clinical use and has been welcomed by the majority of lung cancer patients as a targeted drug. The sexual drug Iressa targets lung cancer cells and has little effect on other normal cells, so the side effects are also small and within people's tolerance. As a targeted anti-cancer drug, Iressa has opened up new treatment ideas and concepts for lung cancer and even all cancers. It has moved away from traditional chemotherapy. With the development of cell genetics, it has been interpreted from a molecular perspective to treat lung cancer. And it has achieved very good results, leading the current new trend in lung cancer treatment.
- - What should I do if drug resistance develops while taking it?
Answer As the currently widely used anti-cancer drug Iressa does have extremely obvious advantages over previous traditional treatments in terms of efficacy and side effects. It can effectively act on lung cancer cells to prevent them from dividing and stabilize them. Controlling the disease also has little impact on normal cells in lung cancer patients due to the targeting principle. What should I do if drug resistance develops while taking Iressa? Zhang Qin, an expert from the Chengdu Military Region General Hospital, said that the problem of drug resistance varies from person to person while taking Iressa. Drug resistance often appears after half a year or a few years. You cannot stop taking the medication because it will easily cause relapse and the effect will be lost if you take it again. Don’t worry when resistance to Iressa occurs, because even if resistance to Iressa occurs, the lung cancer has been effectively controlled, and treatment with other therapies can stabilize the disease. To achieve targeted, systematic and reasonable treatment of lung cancer to ensure life. When resistance to Iressa occurs, combination therapy can be sought. Iressa can be organically combined with traditional surgical treatment for combined treatment, or other related anti-cancer drugs can be selected to be paired with Iressa to stabilize the condition. Of course, all this must be done under the arrangement of the doctor and selected according to the individual's body and condition recovery.
- - Question: Can lactating women take Iressa?
Answer: Iressa, as a small molecule targeted anti-cancer drug, prevents lung cancer by inhibiting r autophosphorylation and blocking conduction. The self-proliferation of cells can effectively control lung cancer to achieve the purpose of treatment. Zhang Qin, an expert from Chengdu Military Region General Hospital, said that there are currently no records related to the use of Iressa by lactating women. However, some biochemical experiments have shown that some metabolic substances such as Iressa will increase when lactating rats are given Iressa. The body's circulation is widely secreted into breast milk. As a result, milk contains a large amount of Iressa metabolites. In addition, further research found that the survival rate of young mice given Iressa to female mice during pregnancy and childbirth would be affected. Therefore, we here suggest that lung cancer patients who are breastfeeding should suspend breastfeeding as much as possible while using Iressa to avoid any impact on their children, and they can find other milk sources to support their children. Clinical studies have shown that Iressa is a fairly safe method in the treatment of lung cancer. The overall tolerability of the drug is very strong. Some adverse side effects are only mild symptoms such as nausea, vomiting, rash, etc., and do not require medical treatment and occur at a very low frequency. It is a trustworthy anti-cancer drug that has a small efficacy compared with the probability and is also outstanding.
WhatsApp
